WorldQuant Millennium Advisors
MRNA icon

WorldQuant Millennium Advisors’s Moderna MRNA Stock Holding History

WorldQuant Millennium Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-143,431
Closed -$3.7M – 622
2025
Q3 		$3.7M Sell
143,431
-697,164
-83% -$19.4M 0.02% 318
2025
Q2 		$23.2M Buy
+840,595
New +$22.1M 0.12% 190
2022
Q1 		– Sell
-32,002
Closed -$8.13M – 336
2021
Q4 		$8.13M Sell
32,002
-31,142
-49% -$9.11M 0.16% 178
2021
Q3 		$24.3M Sell
63,144
-17,412
-22% -$6.42M 0.53% 50
2021
Q2 		$18.9M Buy
+80,556
New +$14.4M 0.42% 82
2021
Q1 		– Sell
-92,347
Closed -$9.65M – 356
2020
Q4 		$9.65M Buy
92,347
+71,141
+335% +$7.2M 0.21% 163
2020
Q3 		$1.5M Buy
21,206
+8,537
+67% +$595K 0.04% 294
2020
Q2 		$813K Buy
+12,669
New +$694K 0.02% 320

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

WorldQuant Millennium Advisors's MRNA Position: Q4 2025 in Review

WorldQuant Millennium Advisors sold out of Moderna (MRNA) in Q4 2025, closing a stake of 143,431 shares — an estimated $3.7M sold.

WorldQuant Millennium Advisors first reported a position in MRNA in Q2 2020 and held it in 8 quarters. The position peaked at $24.3M in Q3 2021. 672 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • WorldQuant Millennium Advisors reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • WorldQuant Millennium Advisors sold 143,431 Moderna shares in Q4 2025, an estimated $3.7M.
  • WorldQuant Millennium Advisors first reported a position in Moderna in Q2 2020 and held it in 8 quarters.
  • WorldQuant Millennium Advisors's Moderna position peaked at $24.3M in Q3 2021.
  • 672 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on WorldQuant Millennium Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.